CYP2E1 and metabolic dysfunction-associated steatotic liver disease: In contrast, robust CYP2E1 induction, lobular inflammation, low basal concentrations of hepatic GSH and NASH-associated mitochondrial dysfunction might favor APAP hepatotoxicity in obesity and NAFLD (Figure 2A).